Stock listing

Jacobio Pharmaceuticals Group Co., Ltd.

Selected listing: 1167 · HKEX · HKD · HK

Jacobio Pharmaceuticals Group Co., Ltd. (HKEX:1167), Health Technology. Latest release Mar 10, 2026: Jacobio Announces 2025 Annual Results.

1167:HKEXHKDHKUpdated October 2, 2026

Ticker: HKEX:1167
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: HKEX
Currency: HKD

About Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd. is a public company listed on the Hong Kong Stock Exchange under the ticker 1167. Jacobio focuses on the development of innovative therapies in the field of pharmaceuticals.

Latest news from Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Announces 2025 Annual Results

March 10, 2026

Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73

December 21, 2025

Jacobio Presents Pre-Clinical Data of Pan-KRAS Inhibitor (JAB-23E73) at AACR-NCI-EORTC International Conference

October 23, 2025

Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline

October 15, 2025

Jacobio Chairman and Concerted Parties Increase Shareholding by Nearly HK$100 Million, Demonstrating Confidence in Long-term Growth

September 24, 2025

All Jacobio Pharmaceuticals Group Co., Ltd. news →

Research Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd. company profile

View the public company page for Jacobio Pharmaceuticals Group Co., Ltd. on 6ix.

Jacobio Pharmaceuticals Group Co., Ltd. news

Read company news and market updates connected to Jacobio Pharmaceuticals Group Co., Ltd..

Jacobio Pharmaceuticals Group Co., Ltd. investor events

Find investor webinars, events, and replay context for Jacobio Pharmaceuticals Group Co., Ltd..